News

GlaxoSmithKline (GSK) has said that all rights to ispinesib and SB-743921, each novel inhibitors of kinesin spindle protein (KSP), will revert to Cytokinetics, on agreed terms. The collaboration

Dr Reddy’s is also expected to market a generic version of the Clarinex 5mg tablet six months after the launch of the first generic version of that product. The agreements

Generex Oral-lyn is expected to be designed to offer a pain-free alternative to prandial injections of insulin. Benta, the company’s licensee in Lebanon is said to be poised to start

Neurotronics becomes a subsidiary of Nihon Kohden on December 31, 2008. Nihon Kohden is expected to strengthen its position as a leader in the neurology business with the

NicVAX is an investigational vaccine being developed by Nabi to treat nicotine addiction and prevent smoking relapse. NicVAX is designed to stimulate the immune system to produce antibodies

Zolpimist is NovaDel’s second product approved by the FDA that uses the company’s proprietary NovaMist oral spray technology. Zolpimist contains zolpidem tartrate, the same active ingredient as Ambien,

ViRexx has three proprietary technology platforms Chimigen vaccine platform, T-ACT platform and the AIT platform. The Chimigen platform is a versatile platform technology being used primarily to generate

The indications for which Amgen is seeking FDA approval are treatment and prevention of postmenopausal osteoporosis (PMO) in women, and treatment and prevention of bone loss in patients

The FDA has accepted an investigational new drug application (IND) for ARQ 621, and the company plans to initiate a Phase I clinical trial with this compound in